Full Text View
Tabular View
Study Results
Related Studies
Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"
This study has been completed.
Study NCT00139776   Information provided by Pfizer
First Received: August 29, 2005   Last Updated: June 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoarthritis, Knee
Osteoarthritis, Hip
Additional conditions recognized in this trial
Osteoarthritis
More general conditions related to this trial
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
Celecoxib
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services